Related Experiment Video
Updated: Aug 17, 2026
Computerized Adaptive Testing System of Functional Assessment of Stroke
Published on: January 7, 2019
Stroke: a case review
1Coronary Care Unit, Long Island Jewish Medical Center, New Hyde Park, New York, USA. Vibtach@Medscape.com
Insights
Primary prevention is crucial for stroke management, even when using antithrombotic and antiplatelet drugs. This approach is key to effectively managing stroke, a leading cause of death and disability.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Stroke is a sudden neurological deficit from brain ischemia or hemorrhage.
- It is the third leading cause of death in the U.S., impacting over 730,000 annually.
- Stroke care costs approximately $40 billion each year.
Observation:
- This case report details stroke management strategies.
- The study considered patients receiving antithrombotic and antiplatelet therapies.
- Treatment effectiveness was evaluated in the context of patient outcomes.
Findings:
- Standard treatments like antithrombotics and antiplatelets may not be sufficient alone.
- Primary prevention strategies are highlighted as the most critical factor.
- Effective stroke management relies heavily on preventative measures.
Implications:
- Emphasizes the need for robust primary stroke prevention programs.
- Suggests a shift in focus from solely treatment to prevention.
- Informs clinical practice and public health policy regarding stroke.
Abstract:
Stroke is indicated by an abrupt manifestation of neurologic deficits secondary to an ischemic or hemorrhagic insult to a region of the brain. Stroke is ranked as the third leading cause of death in the United States, affects more than 730,000 individuals per year, and accounts for 160,000 deaths annually. Approximately $40 billion is spent annually for health care treating stroke victims. This case report shows that despite the use of antithrombotic and/or antiplatelet aggregating drugs, the key to stroke management is primary prevention.
